Self-Assembled TLR7/8 Agonist-Mannose Conjugate as An Effective Vaccine Adjuvant for SARS-CoV-2 RBD Trimer

Small synthetic TLR7/8-agonists can be used as vaccine adjuvants to enhance cell and humoral-mediated immune responses to specific antigens. Despite their potency, after local injection they can be dispersed to undesired body parts causing high reactogenicity, limiting their clinical applications. H...

Full description

Bibliographic Details
Main Authors: Changcai Teng, Xiongyan Meng, Yeqin Hu, Hongzhao Mao, Huiting Li, Jing Yang, Tiantian Sun, Shuai Meng, Chengli Zong
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Polymers
Subjects:
Online Access:https://www.mdpi.com/2073-4360/14/24/5466
_version_ 1797455584267599872
author Changcai Teng
Xiongyan Meng
Yeqin Hu
Hongzhao Mao
Huiting Li
Jing Yang
Tiantian Sun
Shuai Meng
Chengli Zong
author_facet Changcai Teng
Xiongyan Meng
Yeqin Hu
Hongzhao Mao
Huiting Li
Jing Yang
Tiantian Sun
Shuai Meng
Chengli Zong
author_sort Changcai Teng
collection DOAJ
description Small synthetic TLR7/8-agonists can be used as vaccine adjuvants to enhance cell and humoral-mediated immune responses to specific antigens. Despite their potency, after local injection they can be dispersed to undesired body parts causing high reactogenicity, limiting their clinical applications. Here we describe a vaccination strategy that employs the covalent conjugate of a mannose and TLR7/8 agonist as a vaccine adjuvant to take advantage of mannose binding C-type lectins on dendritic cells to enhance the vaccine’s immunogenicity. The mannose-TLR7/8 agonist conjugate can self-assemble into nanoparticles with the hydrophilic mannose on the outside and hydrophobic TLR7/8 agonist inside. Although its ability to stimulate HEK-Blue<sup>TM</sup> hTLR7/8 cells dropped, it can efficiently stimulate mouse bone marrow-derived dendritic cells as indicated by the up-regulation of CD80 and CD86, and higher cytokine expression levels of TNF-α, IL6, and IL-12p70 than the native TLR7/8 agonist. In vivo, vaccination using the SARS-CoV-2 RBD trimer as the antigen and the conjugate as the adjuvant induced a significantly higher amount of IgG2a. These results suggest that the mannose-TLR7/8-agonist conjugate can be used as an effective vaccine adjuvant.
first_indexed 2024-03-09T15:56:24Z
format Article
id doaj.art-5aea92c613434265b7127c2d78b22523
institution Directory Open Access Journal
issn 2073-4360
language English
last_indexed 2024-03-09T15:56:24Z
publishDate 2022-12-01
publisher MDPI AG
record_format Article
series Polymers
spelling doaj.art-5aea92c613434265b7127c2d78b225232023-11-24T17:32:37ZengMDPI AGPolymers2073-43602022-12-011424546610.3390/polym14245466Self-Assembled TLR7/8 Agonist-Mannose Conjugate as An Effective Vaccine Adjuvant for SARS-CoV-2 RBD TrimerChangcai Teng0Xiongyan Meng1Yeqin Hu2Hongzhao Mao3Huiting Li4Jing Yang5Tiantian Sun6Shuai Meng7Chengli Zong8Key Laboratory of Tropical Biological Resources of Ministry of Education, School of Pharmaceutical Sciences, Hainan University, Haikou 570228, ChinaKey Laboratory of Tropical Biological Resources of Ministry of Education, School of Pharmaceutical Sciences, Hainan University, Haikou 570228, ChinaMAXVAX Bio-tech Co., Ltd., Chengdu 610200, ChinaKey Laboratory of Tropical Biological Resources of Ministry of Education, School of Pharmaceutical Sciences, Hainan University, Haikou 570228, ChinaKey Laboratory of Tropical Biological Resources of Ministry of Education, School of Pharmaceutical Sciences, Hainan University, Haikou 570228, ChinaKey Laboratory of Tropical Biological Resources of Ministry of Education, School of Pharmaceutical Sciences, Hainan University, Haikou 570228, ChinaKey Laboratory of Tropical Biological Resources of Ministry of Education, School of Pharmaceutical Sciences, Hainan University, Haikou 570228, ChinaKey Laboratory of Tropical Biological Resources of Ministry of Education, School of Pharmaceutical Sciences, Hainan University, Haikou 570228, ChinaKey Laboratory of Tropical Biological Resources of Ministry of Education, School of Pharmaceutical Sciences, Hainan University, Haikou 570228, ChinaSmall synthetic TLR7/8-agonists can be used as vaccine adjuvants to enhance cell and humoral-mediated immune responses to specific antigens. Despite their potency, after local injection they can be dispersed to undesired body parts causing high reactogenicity, limiting their clinical applications. Here we describe a vaccination strategy that employs the covalent conjugate of a mannose and TLR7/8 agonist as a vaccine adjuvant to take advantage of mannose binding C-type lectins on dendritic cells to enhance the vaccine’s immunogenicity. The mannose-TLR7/8 agonist conjugate can self-assemble into nanoparticles with the hydrophilic mannose on the outside and hydrophobic TLR7/8 agonist inside. Although its ability to stimulate HEK-Blue<sup>TM</sup> hTLR7/8 cells dropped, it can efficiently stimulate mouse bone marrow-derived dendritic cells as indicated by the up-regulation of CD80 and CD86, and higher cytokine expression levels of TNF-α, IL6, and IL-12p70 than the native TLR7/8 agonist. In vivo, vaccination using the SARS-CoV-2 RBD trimer as the antigen and the conjugate as the adjuvant induced a significantly higher amount of IgG2a. These results suggest that the mannose-TLR7/8-agonist conjugate can be used as an effective vaccine adjuvant.https://www.mdpi.com/2073-4360/14/24/5466adjuvantsmannoseTLR7/8 agonistimmune responsescytokinesantibody
spellingShingle Changcai Teng
Xiongyan Meng
Yeqin Hu
Hongzhao Mao
Huiting Li
Jing Yang
Tiantian Sun
Shuai Meng
Chengli Zong
Self-Assembled TLR7/8 Agonist-Mannose Conjugate as An Effective Vaccine Adjuvant for SARS-CoV-2 RBD Trimer
Polymers
adjuvants
mannose
TLR7/8 agonist
immune responses
cytokines
antibody
title Self-Assembled TLR7/8 Agonist-Mannose Conjugate as An Effective Vaccine Adjuvant for SARS-CoV-2 RBD Trimer
title_full Self-Assembled TLR7/8 Agonist-Mannose Conjugate as An Effective Vaccine Adjuvant for SARS-CoV-2 RBD Trimer
title_fullStr Self-Assembled TLR7/8 Agonist-Mannose Conjugate as An Effective Vaccine Adjuvant for SARS-CoV-2 RBD Trimer
title_full_unstemmed Self-Assembled TLR7/8 Agonist-Mannose Conjugate as An Effective Vaccine Adjuvant for SARS-CoV-2 RBD Trimer
title_short Self-Assembled TLR7/8 Agonist-Mannose Conjugate as An Effective Vaccine Adjuvant for SARS-CoV-2 RBD Trimer
title_sort self assembled tlr7 8 agonist mannose conjugate as an effective vaccine adjuvant for sars cov 2 rbd trimer
topic adjuvants
mannose
TLR7/8 agonist
immune responses
cytokines
antibody
url https://www.mdpi.com/2073-4360/14/24/5466
work_keys_str_mv AT changcaiteng selfassembledtlr78agonistmannoseconjugateasaneffectivevaccineadjuvantforsarscov2rbdtrimer
AT xiongyanmeng selfassembledtlr78agonistmannoseconjugateasaneffectivevaccineadjuvantforsarscov2rbdtrimer
AT yeqinhu selfassembledtlr78agonistmannoseconjugateasaneffectivevaccineadjuvantforsarscov2rbdtrimer
AT hongzhaomao selfassembledtlr78agonistmannoseconjugateasaneffectivevaccineadjuvantforsarscov2rbdtrimer
AT huitingli selfassembledtlr78agonistmannoseconjugateasaneffectivevaccineadjuvantforsarscov2rbdtrimer
AT jingyang selfassembledtlr78agonistmannoseconjugateasaneffectivevaccineadjuvantforsarscov2rbdtrimer
AT tiantiansun selfassembledtlr78agonistmannoseconjugateasaneffectivevaccineadjuvantforsarscov2rbdtrimer
AT shuaimeng selfassembledtlr78agonistmannoseconjugateasaneffectivevaccineadjuvantforsarscov2rbdtrimer
AT chenglizong selfassembledtlr78agonistmannoseconjugateasaneffectivevaccineadjuvantforsarscov2rbdtrimer